Sophia George named associate director of DEI; Ashish Shah named director of clinical trials, translational research at Sylvester

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Sophia George was named the inaugural associate director of diversity, equity, and inclusion, and Ashish Shah was named director of clinical trials and translational research and principal investigator in the Section of Virology and Immunotherapy at Sylvester Comprehensive Cancer Center’s Brain Tumor Initiative at the University of Miami Miller School of Medicine. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Positive high-level results from the POTOMAC phase III trial showed one year of treatment with Imfinzi (durvalumab) plus standard-of-care BCG induction and maintenance therapy demonstrated a statistically significant and clinically meaningful improvement in disease-free survival for patients with high-risk non-muscle-invasive bladder cancer compared to BCG induction and maintenance therapy alone.​

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login